Biotech

All Articles

BioAge eyes $180M coming from IPO, private positioning for weight problems tests

.BioAge Labs is actually looking at around $180 million in preliminary profits from an IPO as well a...

Merck's LAG-3 combo stops working colorectal cancer cells phase 3 study

.An attempt by Merck &amp Co. to uncover the microsatellite secure (MSS) metastatic intestines cance...

Spanish VC shuts $200M lifestyle sciences fund

.Spain-based Asabys Partners has shut a fund of 180 thousand europeans ($ 200 thousand), amount of m...

BioAge produces $198M coming from IPO as being overweight biotech signs up with Nasdaq

.BioAge Labs is bringing in practically $200 million using its Nasdaq IPO this morning, with the pro...

Acadia brings BMS veterinarian aboard as CEO-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our summary of considerable leadership hirings, shootings...

Cassava pays for $40M over apparently deceptive Alzheimer's improve

.Cassava Sciences has actually agreed to pay for $40 thousand to fix an examination in to claims it ...

Merck bags alternatives on Evaxion's AI-designed injection prospects

.Merck &amp Co. has picked up options on two Evaxion Biotech vaccination prospects, paying $3.2 mill...

Enanta's RSV antiviral crushes virus-like bunch in difficulty research study

.Enanta Pharmaceuticals has connected its breathing syncytial infection (RSV) antiviral to significa...

Biogen cans SAGE-324 collaboration after vital tremor stop working

.Biogen has actually conducted the last rites to its own cooperation along with Sage Therapeutics on...

AbbVie Parkinson's medicine from $8.7 B Cerevel buyout scores

.On the exact same time that some Parkinson's condition medications are actually being actually brou...